首页> 美国卫生研究院文献>Rheumatology and Therapy >A Retrospective Analysis of Corticosteroid Utilization Before Initiation of Biologic DMARDs Among Patients with Rheumatoid Arthritis in the United States

【2h】

A Retrospective Analysis of Corticosteroid Utilization Before Initiation of Biologic DMARDs Among Patients with Rheumatoid Arthritis in the United States

机译：美国类风湿性关节炎患者开始使用生物DMARD之前使用皮质类固醇的回顾性分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

IntroductionUnderstanding the effects of corticosteroid utilization prior to initiation of biologic disease-modifying antirheumatic drugs (DMARDs) can inform decision-makers on the appropriate use of these medications. This study examined treatment patterns and associated burden of corticosteroid utilization before initiation of biologic DMARDs among rheumatoid arthritis (RA) patients.

机译：简介了解在开始使用可改善生物疾病的抗风湿药（DMARD）之前使用皮质类固醇的作用可为决策者提供有关这些药物的适当使用的信息。这项研究检查了类风湿性关节炎（RA）患者开始生物DMARDs之前的治疗模式和相关的皮质类固醇利用负担。

著录项

期刊名称 Rheumatology and Therapy
作者
Christina A. Spivey; Jenny Griffith; Cameron Kaplan; Arnold Postlethwaite; Arijit Ganguli; Junling Wang;
展开▼
作者单位

展开▼
年(卷),期 2018(5),1
年度 2018
页码 255–270
总页数 16
原文格式 PDF
正文语种
中图分类免疫性疾病;
关键词
Adverse events Biologic disease-modifying antirheumatic drugs (DMARDs) Corticosteroids Healthcare costs Healthcare utilization Rheumatoid arthritis;

机译：不良事件;修饰生物病的抗风湿药（DMARD）;糖皮质激素;医疗保健费用;医疗保健利用;类风湿关节炎;

相似文献

外文文献
中文文献
专利

1. A Retrospective Analysis of Corticosteroid Utilization Before Initiation of Biologic DMARDs Among Patients with Rheumatoid Arthritis in the United States [J] . Christina A. Spivey, Jenny Griffith, Cameron Kaplan, Rheumatology and Therapy . 2018,第1期

机译：美国类风湿性关节炎患者开始使用生物DMARD之前使用皮质类固醇的回顾性分析
2. Retrospective Analysis of the Impact of Adalimumab Initiation on Corticosteroid Utilization and Medical Costs Among Biologic-Na?ve Patients with Rheumatoid Arthritis [J] . Christina A. Spivey, Kevin L. Winthrop, Jenny Griffith, Rheumatology and Therapy . 2020,第1期

机译：复发性分析患者对类风湿性关节炎患者皮质类固醇利用和医疗成本的影响
3. Delay in initiation of DMARD or anti-inflammatory therapy in patients newly diagnosed with rheumatoid arthritis: An analysis of United States Military Health System TRICARE beneficiaries [J] . Kimsey Linda, Weissman Joel S., Patel Avni, Seminars in Arthritis and Rheumatism . 2019,第5期

机译：新诊断为类风湿性关节炎的患者的DMARD或抗炎治疗开始的延迟：美国军事卫生系统TRICARE受益人分析
4. THE INCIDENCE, AND POLARIZATION OPTICAL CHARACTERISTICS OF PULMONARY ALVEOLAR CALCOSPHER1TIES (CORPORA AMYLACEA) IN RHEUMATOID ARTHRITIS - A RETROSPECTIVE CLINICOPATHOLOGIC STUDY OF 210 AUTOPSY PATIENTS [C] . Miklos Bely, Agnes Apath International Symposium on Amyloidosis . 2005

机译：类风湿性关节炎肺肺泡煅烧煤层1型（Corpora Amylacea）的发病率和偏振光学特性 - 对210例尸检患者的回顾性临床病理学研究
5. Medication Utilization for Rheumatoid Arthritis Among Commercially Insured Patients [D] . Reidt, Shannon. 2020

机译：商业保险患者中类风湿性关节炎的药物利用
6. Retrospective Analysis of the Impact of Adalimumab Initiation on Corticosteroid Utilization and Medical Costs Among Biologic-Naïve Patients with Rheumatoid Arthritis [O] . Christina A. Spivey, Kevin L. Winthrop, Jenny Griffith, 2020

机译：回顾性分析阿达木单抗对未接受过生物治疗的类风湿关节炎患者皮质类固醇利用和医疗费用的影响
7. A Retrospective Analysis of Corticosteroid Utilization Before Initiation of Biologic DMARDs Among Patients with Rheumatoid Arthritis in the United States [O] . Christina A. Spivey, Jenny Griffith, Cameron Kaplan, 2017

机译：在美国类风湿性关节炎患者中生物学DMARD患者开始前皮质类固醇利用的回顾性分析

A Retrospective Analysis of Corticosteroid Utilization Before Initiation of Biologic DMARDs Among Patients with Rheumatoid Arthritis in the United States

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅